Atlas Trials

Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons

Clinical trial NCT02572323 · COMPLETED

Trial details

NCT number
NCT02572323
Sponsor
University of California, San Diego
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Mild Cognitive Impairment
Start date
2017-02-15
Primary completion
2023-10-15
Enrollment
73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.